Loading...
XASE
VTAK
Market cap8mUSD
Jul 09, Last price  
1.14USD
1D
-16.79%
1Q
-4.20%
IPO
-100.00%
Name

Ra Medical Systems Inc

Chart & Performance

D1W1MN
XASE:VTAK chart
P/E
P/S
8.99
EPS
Div Yield, %
Shrs. gr., 5y
695.22%
Rev. gr., 5y
25.89%
Revenues
819k
+95.00%
5,976,0005,870,0006,257,0007,199,000259,00022,00014,000442,000420,000819,000
Net income
-17m
L+3.24%
-4,202,000-17,765,000-30,832,000-56,957,000-36,045,000-25,070,000-26,865,000-70,572,000-16,643,000-17,183,000
CFO
-8m
L-10.52%
-1,886,000-5,523,000-18,508,000-33,173,000-28,304,000-27,625,000-22,568,000-20,619,000-9,271,000-8,296,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Catheter Precision, Inc., headquartered in Fort Mill, South Carolina, is dedicated to creating and distributing electrophysiology products. Their mission is to enhance treatment and outcomes for U.S. patients suffering from cardiac arrhythmias by providing innovative technologies and solutions to patients, hospitals, and physicians. Their premier product, the View into Ventricular Onset System (VIVO), is a non-invasive 3D cardiac mapping solution designed to accurately locate the origin points of idiopathic ventricular arrhythmias in patients with otherwise healthy hearts, before they undergo electrophysiology procedures. Additionally, they offer LockeT, a device for suture retention, and the Amigo Remote Catheter System, a robotic arm used for precise catheter control. The company, previously known as Ra Medical Systems, Inc., officially adopted the name Catheter Precision, Inc. in August 2023.
IPO date
Sep 27, 2018
Employees
14
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT